TD Cowen cuts HubSpot stock price target on pricing changes By Investing.com

TD Cowen cut HubSpot's price target to $250 from $270 while keeping a Hold rating, citing softer Q2 guidance, lengthening sales cycles, and disruption from new outcome-based pricing and 50% AI price cuts. The company still posted about a 2% constant-currency revenue beat and has strong fundamentals, including 84% gross margins and more cash than debt. Even so, the stock has fallen 63% over the past year and now trades at $243.72 versus a 52-week high of $682.57.

Analysis

The market is starting to price HUBS less as a high-quality compounder and more as a transition story with temporary margin friction. The key second-order effect is that pricing/package changes can suppress expansion just as the sales cycle is lengthening, which creates a short-term negative loop: reps need more time to retrain, buyers need more time to re-underwrite ROI, and booking visibility worsens even if underlying product demand is intact. That typically pressures the multiple before it shows up in revenue, especially for a name where sentiment still anchors on historical growth rates.

The competitive dynamic is subtle: if HubSpot is forced to simplify or discount AI add-ons to preserve conversion, it may widen the gap between “broad platform” vendors and point solutions that can price AI more cleanly. That benefits fast-moving marketing/sales tooling vendors with narrower use cases, while incumbents with weaker packaging discipline risk looking expensive on a bundle-adjusted basis. Over the next 1-2 quarters, the real tells will be net retention inflection and pipeline conversion, not headline revenue.

Tail risk is that these packaging changes become a multi-quarter drag rather than a one-off reset; if so, consensus estimates are still too high because the market is likely underestimating how long it takes to re-baseline customer cohorts after pricing changes. The upside catalyst is equally clear: if management can show stable expansion in up-market cohorts and AI monetization improves without further discounts, the stock could re-rate quickly because the balance sheet and gross margin profile limit fundamental downside. In other words, this is a classic multiple-vs-fundamentals mismatch: the business is not broken, but the transition could keep the stock range-bound for several months.

Key Decisions for Investors

• Short HUBS on strength or via call spreads into any post-earnings bounce; target 1-2 quarter horizon where estimate revisions likely remain negative. Risk/reward favors a tactical short while the market is still digesting packaging friction, with a stop if management shows re-acceleration in billings or stable net retention.
• Pair trade: long a profitable horizontal SaaS name with cleaner monetization visibility, short HUBS, to isolate pricing-transition risk from sector beta. Best held 3-6 months; thesis works if investors keep rewarding visible ARR compounding over product-transition stories.
• Buy HUBS put spreads 1-2 earnings out rather than outright puts; implied downside is already partially reflected, but another guide-down on sales-cycle length could produce a sharp move. This structure caps theta bleed while preserving convexity if estimates are cut again.
• For longer-term accounts, wait for evidence of packaging stabilization before rebuilding longs; use a 2-quarter confirmation rule on billings and net retention. If those metrics stabilize, the current de-rating could become a setup for a medium-term rerating trade.
• Watch for a relative short against high-multiple SaaS peers only if HUBS guidance continues to underwhelm; if the AI pricing cut is narrowed or reversed, cover quickly because the stock can squeeze hard on any sign that the transition is temporary.